Identifying High‐Impact Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus‐Based Approach
Addressing health and health care disparities linked to negative SDoH is a key goal in the management of lupus, as disparities in outcomes can be stark. Increasing the visibility of potential solutions and aligning the community on top priorities can enable more efficient and effective contributions to health care equity and ultimately better health outcomes for people living with lupus.
Authors
- Joy Buie (ORCID: https://orcid.org/0000-0003-4026-4812)
- Edith M. Williams (ORCID: https://orcid.org/0000-0002-3933-3019)
- Sung Sam Lim (ORCID: https://orcid.org/0000-0003-2361-0787)
- Kristen Backor
- Candace H. Feldman (ORCID: https://orcid.org/0000-0002-4980-9770)
- Michael Fisher (ORCID: https://orcid.org/0000-0003-2223-2737)
- Ed Yelin (ORCID: https://orcid.org/0000-0002-9229-9980)
- Ashira Blazer (ORCID: https://orcid.org/0000-0002-0386-5259)
- Karen H. Costenbader (ORCID: https://orcid.org/0000-0002-8972-9388)
- Andrea Knight (ORCID: https://orcid.org/0000-0003-4278-9049)
- B. Frank Polk
- Hannah Tyldsley
Institutions
- University of Maryland, Baltimore (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Emory University (US)
- University of California, San Francisco (US)
- University of Toronto (CA)
- Hospital for Sick Children (CA)
- Lupus Foundation of America (US)
- University of Rochester Medical Center (US)
- Jobs for the Future (US)
- SickKids Foundation (CA)
- Charles River Associates (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1002/acr.25635
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- AstraZeneca
- GlaxoSmithKline
- Biogen
- Mallinckrodt Pharmaceuticals
- Genentech
- EMD Serono